Merck site to reopen as biotech breeding ground

What do you do with an old research site? You make it into a new one. Merck ($MRK) has donated its research facility at Newhouse, Scotland, including equipment and a library of 100,000 compounds, to BioCity Scotland, a joint venture between BioCity Nottingham and Roslin BioCentre. The 23-acre site, including 130,000 square feet of purpose-built laboratories and offices, as well as administrative and conference facilities, will create a life science cluster by providing space for start-up and growing companies. The site closed in July 2010, and this move could bring much needed jobs and inward investment to this region of Scotland. Release | Article

Suggested Articles

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.

Gilead presented studies at AASLD showing how noninvasive testing and machine learning could improve diagnostics and drug development for NASH.